Tai-Chi and lactulose team up to fight falls in liver disease
NCT ID NCT05794555
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tested whether a two-step treatment plan using lactulose (a medicine) followed by virtual Tai-Chi can reduce falls and other serious problems in people with cirrhosis and portal hypertension. Over 24 weeks, 230 participants were randomly assigned to different treatment sequences. The goal was to see if this approach lowers the risk of falls, confusion episodes, liver transplants, or death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott & White Research Institute (BSW)
Dallas, Texas, 75246, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.